In this study, the frequency of extended-spectrum b-lactamases (ESBL) and plasmid-mediated quinolone resistance (PMQR) mechanisms were investigated in 206 clinical isolates of thirdgeneration cephalosporin (3GC)-resistant Enterobacteriaceae in four hospitals in the Republic of Ireland. bla CTX-M-15 was the predominant ESBL gene. Of these 3GC resistant isolates, 54 % were also resistant to ciprofloxacin. Investigation of the PMQR mechanisms revealed that the aac (69) Ib-cr gene predominated in fluoroquinolone-resistant (FQR) strains of Escherichia coli and Klebsiella pneumoniae, while the qnrA gene predominated in the FQR strains of Enterobacter.
INTRODUCTION
Since the first description of extended-spectrum b-lactamases (ESBLs) in 1983, incidences of ESBL-producing bacterial strains have been reported increasingly worldwide (Cantó n et al., 2008) . In Europe there has been a transition from the dominance of the bla TEM and bla SHV genes towards a greater prevalence of bla CTX-M genes in ESBL-producing members of the family Enterobacteriaceae (Bonnet, 2004) . These multi-drug resistance genes are frequently located on plasmids. Associations between CTX-M-type ESBLs and resistance to other antimicrobial agents have been identified in surveys from many countries including Canada, Greece, the UK and Italy. The fluoroquinolone (FQ) resistance genes qnr and aac(69)Ib-cr have been frequently associated with b-lactamase-mediated resistance, conferred by bla TEM , bla SHV and bla CTX-M genes Woodford et al., 2009) . The dissemination of these ESBL genes and plasmid-mediated quinolone resistance (PMQR) is making it increasingly difficult to manage infections caused by multi-drug resistant (MDR) strains of Enterobacteriaceae.
There have been relatively limited data published on MDR Enterobacteriaceae isolates from the Republic of Ireland. As part of the data collected for the European Antibiotic Resistance Surveillance Network (EARS-Net, 2010) , the rates of third-generation cephalosporin (3GC) and FQ resistance in invasive Escherichia coli isolates reported from the ROI in 2009 were 6.5 % and 21.7 %, respectively, while the rates of 3GC and FQ resistance in Klebsiella pneumoniae isolates were 11.1 % and 10.8 %, respectively. The proportions of 3GC-resistant E. coli and K. pneumoniae in which ESBL production was also detected were 85.5 % and 78.1 %, respectively. The aims of the present study were to identify the mechanisms of plasmidmediated resistance to 3GCs and FQs in MDR Enterobacteriaceae isolates collected from four Irish hospitals, characterize the plasmids harbouring the aac(69)Ib-cr gene, and investigate the ability of these plasmids to enhance the development of ciprofloxacin resistance in Escherichia coli.
METHODS
Bacterial strains. Clinical isolates of E. coli, K. pneumoniae and Enterobacter were collected from a 900-bed tertiary referral university hospital in the Republic of Ireland between July 2006 and June 2008 (CLSI, 2007) . The bacteria, which were collected from all sites of infection by the diagnostic microbiology laboratory, were screened for resistance to 3GCs cefotaxime and/or ceftazidime using in vitro antibiotic susceptibility testing according to CLSI guidelines, except for isolates of E. coli collected from urinary samples, which were not screened for 3GC resistance. Additionally, 3GC-and FQ-resistant isolates were collected from three other Irish hospitals during the same period and added to the main collection. The total numbers of isolates of E. coli, K. pneumoniae and Enterobacter collected were 73, 56 and 77, respectively.
PCR detection of resistance genes. All isolates were screened for the presence of bla TEM , bla SHV , bla OXA and bla CTX-M genes by using multiplex PCR (Colom et al., 2003; Woodford et al., 2006) . PCRpositive isolates were confirmed by individual PCRs and the purified products were sequenced in the forward and reverse directions using the amplification primers or the primers bla TEM forward 59-AGAT-CAGTTGGGTGCACGAG-39and bla TEM reverse 59-CTTGGTCTGA-CAGTTACC-39 for the bla TEM PCR positives. All isolates, regardless of their susceptibility to FQ, were analysed for the aac(69)Ib-cr gene by using PCR, and for qnrA, qnrB and qnrS genes by using multiplex PCR Gay et al., 2006) . PCR-positive isolates were confirmed by individual PCR and subsequent sequencing in the forward and reverse directions.
Plasmid transformation and profiles. All aac(69)Ib-cr-positive isolates were selected for plasmid analysis. Plasmid extractions were performed using a Qiagen Plasmid Midi kit. Extracted plasmids were transformed into TOP10 competent E. coli cells by electroporation and the cells were spread on Mueller-Hinton agar containing ampicillin, cefotaxime or kanamycin (20 mg l 21 each). All resulting transformant colonies were screened both for the presence of the aac(69)Ib-cr gene and all of the additional plasmid-mediated ESBL genes which were present in the parent clinical isolate. Plasmids were extracted from PCR-positive transformants and E. coli NCTC 13400 (pEK499) cells using the Qiagen Plasmid Midi kit. The extracted plasmids were digested using restriction enzyme PstI and separated on 0.8 % agarose gels at 100 V for 5 min followed by 75 V for 2 h. The resulting banding patterns were analysed using BioNumerics software in order to determine the percentage similarity between the plasmids.
Mutation studies. Transformants and competent cells were individually inoculated into LB broth and incubated at 37 uC overnight. A 100 ml volume of each of the overnight cultures was spread on to Mueller-Hinton agar plates containing ciprofloxacin at concentrations equal to the MIC or 26 MIC for that strain (Walsh et al., 2003) . Plates with each drug concentration, together with a control with no antibiotic, were inoculated in triplicate and incubated at 37 uC for 48 h. The mutants generated were purified by subculturing twice on plates with the selective ciprofloxacin concentration. The MIC of ciprofloxacin for each of the mutants was determined according to the CLSI guidelines (CLSI, 2007) . Successive generations of mutants were derived in the same way as the first generation. This process was repeated using increasingly higher concentrations of ciprofloxacin until high-level resistance was achieved (MIC ¢8 mg l 21 ) or the MICs for successive generations remained constant over two successive generations.
RESULTS AND DISCUSSION

Antibiotic resistance profiles
The prevalence and range of multi-drug resistance in the 206 3GC-resistant isolates are shown in Table 1 . The majority of isolates were collected from hospital 4. Within the 3GCresistant populations from the four hospitals, 41 % of the E. coli, 45 % of the K. pneumoniae and 5 % of the Enterobacter isolates were ESBL-positive. Few strains of K. pneumoniae or E. coli were resistant to imipenem but almost one third of the Enterobacter isolates were imipenem resistant, all of which were isolated from hospital 4. There were significantly higher levels of amikacin resistance in isolates of K. pneumoniae and E. coli when compared to another Irish in all three populations from each hospital, the predominant b-lactamase genes were bla TEM-1 and bla OXA-1 . Five novel ESBL genes, bla TEM-170 to bla TEM-174 , were detected in isolates of E. coli. These were isolated from the four different hospitals. Five novel bla SHV genes were identified: the bla SHV-126 gene was identified in an Enterobacter isolate from hospital 2 and the genes bla SHV-123 , bla SHV-124 , bla SHV-125 and bla SHV-127 were detected in K. pneumoniae isolates from hospitals 2 and 4. Of these, only bla SHV-127 was associated with an ESBL-positive phenotype.
PMQR genes and plasmid epidemiology analysis
It was possible to segregate the predominant PMQR gene determinants based on bacterial species (Table 2) . Isolates of E. coli and K. pneumoniae contained predominantly aac(69)Ib-cr genes and few qnr genes, whereas Enterobacter isolates contained more qnr genes than aac(69)Ib-cr genes. The distribution of resistance genes within isolates from the four hospitals followed this general pattern; however, isolates from hospital 3 contained almost exclusively aac(69)Ib-cr genes. Isolates from hospital 4 contained the largest number of qnr genes, which were more frequently detected than aac(69)Ib-cr genes, indicating an unusual trend within this hospital with a predominance of qnr rather than aac(69)Ib-cr genes. One Enterobacter isolate contained both qnrA and qnrB genes and one isolate of K. pneumoniae was positive for both qnrA and aac(69)Ib-cr genes. To our knowledge, this is the first report of an aac(69)Ib-cr gene identified in Enterobacter aerogenes. All isolates that contained an aac(69)Ib-cr gene were intermediately resistant or resistant to ciprofloxacin; however, three qnrA-positive strains and one qnrB-positive strain were ciprofloxacin-susceptible. The aac(69)Ib-cr gene was always co-located with at least one b-lactamase gene ( Table 2) . The most prevalent combination of b-lactamase and aac(69)Ib-cr gene was aac(69)Ib-cr +bla OXA-1 +bla TEM-1 +bla CTX-M-15 , which was identified in four and seven isolates of K. pneumoniae and E. coli, respectively. This pattern of co-location was detected in isolates from hospitals 2, 3 and 4 but was most pronounced in isolates from hospital 3, with seven isolates harbouring this genotype. These genes were also reported on the pEK499 plasmid in epidemic strains of E. coli from the UK (Woodford et al. 2009 ). The second most frequently identified association of genes was aac(69)Ib-cr+bla OXA-1 +bla CTX-M-15 , which was present in four isolates of E. coli and three isolates of K. pneumoniae. The qnrA and qnrB genes were detected with bla SHV genes in isolates from hospitals 2 and 4.
The transformation studies indicated that the aac(69)Ib-cr gene was always associated with the bla OXA-1 gene and was frequently associated with the genes bla CTX-M-15 and bla TEM-1 . The presumption, in many studies to date, has been that these genes are co-transferred on the same plasmid as they are often identified in the same strains; however, in the transformation studies, in nine of the 19 strains positive for both aac(69)Ib-cr and bla CTX-M-15 genes, the bla CTX-M-15 gene was not co-transferred with aac(69) Ib-cr into competent E. coli cells. The nine clinical strains harbouring these plasmids comprised both K. pneumoniae and E. coli. Digested plasmids from the transformants were compared to each other and to the UK epidemic pEK499, which contains both aac(69)Ib-cr and bla CTX-M-15 genes, using BioNumerics software, as shown in Fig. 1 . The only plasmid profiles that shared 100 % identity were those where plasmids originated from two Enterobacter isolates (transformants 4T and 5T) or from two isolates of K. pneumoniae (transformants 25T and 26T); all four of these plasmids were bla CTX-M-15 -negative. The former of these plasmids were the only two aac(69)Ib-cr-harbouring plasmids identified in Enterobacter isolates in this study. These strains had both been isolated in the same hospital but from different patients. The banding patterns of the remaining plasmids were diverse and did not show any distinct patterns. No plasmids were, therefore, identical to plasmid pEK499; however, it is possible that genetic rearrangement has occurred, which could not have been discerned using restriction analysis.
Generation of ciprofloxacin-resistant mutants from isogenic E. coli transformants containing aac(6 §)Ib-cr plasmids
The cr variant of the aac(69)-Ib gene encodes an aminoglycoside acetyltransferase that confers reduced susceptibility to ciprofloxacin by N-acetylation of its piperazinyl amine . The aac(69)Ib-cr gene has been shown previously to enhance the ability of E. coli to develop ciprofloxacin resistance. The experiments of Robicsek et al. (2006) examined the development of ciprofloxacin resistance when the aac(69)Ib-cr gene was ligated into a well-characterized plasmid and transformed into E. coli. However, in clinical isolates, the aac(69)Ib-cr gene was not present on a plasmid in isolation and, as shown in this and other studies, other genes and elements are present on the same plasmid as the aac (69)Ib-cr gene. Therefore, we sought to examine the abilities of natural plasmids, which contained the aac(69)Ib-cr gene, to enhance the selection of ciprofloxacin resistance. Highly resistant mutants were generated from 16 of the 26 transformants (Table 3) . High-level ciprofloxacinresistant mutants (MIC ¢16 mg l 21 ) were generated from the E. coli competent cells in the fourth generation that lacked an aac(69)Ib-cr plasmid. None of the transformants containing the aac(69)Ib-cr gene generated high-level ciprofloxacin-resistant mutants in less than four generations. High-level resistance in some mutants was achieved in four to five generations. Resistant mutants with MICs of 8 mg l 21 were generated from 11 transformants, resistant mutants with MICs of 4 mg l 21 were generated from two transformants and intermediately resistant mutants (MIC 2 mg l 21 ) were generated from three transformants. Five transformants failed to produce resistant mutants after successive generations. There was no correlation between MICs for the transformants and their ability to generate ciprofloxacin-resistant mutants. However, all of the transformants generated from isolates from hospitals 1 and 2 resulted in high-level resistant mutants with MICs ¢8 mg l 21 . Hospital 3 contained the highest number of aac(69)Ib-cr-positive isolates; however, only four transformants generated mutants with MICs of 8 mg l 21 . Six of the eight transformants obtained from isolates from hospital 4 generated mutants with MICs ¢8 mg l 21 . This suggests a difference in the abilities of isolates from the four hospitals to generate FQR mutants.
Conclusions
This study has identified a high distribution and presence of PMQR and ESBL elements in isolates from each of the hospitals. The bla CTX-M-15 and aac(69)Ib-cr genes were the predominant ESBL and PMQR genes in these isolates as a whole, but the qnr genes were the predominate PMQR elements in hospital 4. There was a wide variety of plasmids carrying similar resistance genes. The qnr PMQR genes emerged most frequently in Enterobacter isolates. Novel ESBL genes were detected in isolates from each of the four hospitals and carbapenem and aminoglycoside resistance was detected in all three bacterial populations from one hospital. This highlights a potential threat to the further treatment of these infections. The epidemiological differences in the presence and colocation of PMQR and ESBL genes between the four hospitals suggest that while each hospital contains PMQR-and ESBL-positive isolates, these are not the result of a particular plasmid spreading through bacterial populations in hospitals or between patients. The results of the mutation studies highlight the differences between the plasmids isolated from the four different hospitals. This is particularly important with respect to hospital 3, which contained the largest number of aac(69)Ib-crpositive isolates but resulted in the lowest number of ciprofloxacin-resistant mutants. Thus, the presence of the aac(69)Ib-cr gene in these isolates did not necessarily result in ciprofloxacin resistance.
